谷歌浏览器插件
订阅小程序
在清言上使用
VIPCreated with Sketch.

Abstract C100: Safety Run-in Results from Phase 3 Study of Canakinumab (CAN) or Placebo in Combination with Pembrolizumab (PEM) Plus Platinum-Based Doublet Chemotherapy (ctx) As 1st Line Therapy in Patients (pts) with Advanced or Metastatic NSCLC (CANOPY-1)

Bruce E. Johnson,Tae Min Kim,T. Jeroen N. Hiltermann,Fabrice Barlesi,Christian Grohe,Yasushi Goto,Orvar Gunnarsson,Tobias Overbeck,Noemi Reguart,Martin Wermke,Gilberto Castro,Enriqueta Felip,Alastair Greystoke,Benjamin J. Solomon,Noelia Nebot,Stephanie Deudon,Anne-Laure Louveau,Vanessa Q. Passos,Daniel S. W. Tan

Molecular Cancer Therapeutics（2019）

引用 1|浏览79
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要